Scarica l'app Stockscreener
2.18
3.54%
-0.08
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ACHV Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$2.26
Aprire:
$2.29
Volume 24 ore:
817.66K
Relative Volume:
3.45
Capitalizzazione di mercato:
$127.99M
Reddito:
-
Utile/perdita netta:
$-32.94M
Rapporto P/E:
-1.964
EPS:
-1.11
Flusso di cassa netto:
$-24.95M
1 W Prestazione:
-37.89%
1M Prestazione:
-48.22%
6M Prestazione:
-41.08%
1 anno Prestazione:
-51.66%
Intervallo 1D:
$2.1506
$2.29
Intervallo di 1 settimana:
$2.00
$2.65
Portata 52W:
$1.84
$5.31
Achieve Life Sciences Inc Stock (ACHV) Company Profile
Nome
Achieve Life Sciences Inc
Settore
Industria
Telefono
425-686-1500
Indirizzo
22722 29TH DR. SE, SEATTLE, BC
Confronta ACHV con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ACHV
Achieve Life Sciences Inc
|
2.18 | 127.99M | 0 | -32.94M | -24.95M | -1.11 |
|
VRTX
Vertex Pharmaceuticals Inc
|
459.62 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
547.36 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
331.91 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
543.48 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
245.49 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Achieve Life Sciences Inc Stock (ACHV) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-11-14 | Iniziato | Rodman & Renshaw | Buy |
| 2024-09-27 | Iniziato | Raymond James | Strong Buy |
| 2023-05-10 | Reiterato | Maxim Group | Buy |
| 2021-06-23 | Iniziato | Oppenheimer | Outperform |
Achieve Life Sciences Inc Borsa (ACHV) Ultime notizie
Bank of America Corp DE Purchases 9,760 Shares of Achieve Life Sciences, Inc. (NASDAQ:ACHV) - Defense World
Institutional investors may adopt severe steps after Achieve Life Sciences, Inc.'s (NASDAQ:ACHV) latest 15% drop adds to a year losses - simplywall.st
Owning 46% shares,institutional owners seem interested in Achieve Life Sciences, Inc. (NASDAQ:ACHV), - Yahoo Finance
Squarepoint Ops LLC Buys Shares of 17,519 Achieve Life Sciences, Inc. (NASDAQ:ACHV) - Defense World
achieve life sciences holds annual meeting with key votes By Investing.com - Investing.com India
Achieve Life Sciences Elects Board at Annual Meeting - TipRanks
achieve life sciences holds annual meeting with key votes - Investing.com
Achieve Life Sciences (NASDAQ:ACHV) Shares Pass Above 200 Day Moving Average – What’s Next? - Defense World
Achieve Life Sciences: FDA Approval Not Assured, But Valuation Justifies Risk (ACHV) - Seeking Alpha
Achieve Life Sciences to Present at the Jefferies Global Healthcare Conference - GlobeNewswire
Late-Stage Smoking Cessation Drug Developer Achieve Life Sciences Sets Key Jefferies Conference Presentation - Stock Titan
Achieve Life Sciences, Inc. (NASDAQ:ACHV) Shares Purchased by Northern Trust Corp - Defense World
Shay Capital LLC Sells 425,000 Shares of Achieve Life Sciences, Inc. (NASDAQ:ACHV) - MarketBeat
ACHV: New Insights from ORCA-3 Study to Be Shared at 2025 Conference | ACHV Stock News - GuruFocus
Achieve Life Sciences to Present New Data at the 2025 ATS International Conference Demonstrating that Cytisinicline Reduced Cravings and Nicotine Intake | ACHV Stock News - GuruFocus
Achieve Life Sciences to Present Phase 3 Study Findings on Cytisinicline for Smoking Cessation at 2025 ATS Conference - Nasdaq
Achieve Life Sciences to Present New Data at the 2025 ATS - GlobeNewswire
New Clinical Data Shows Cytisinicline Cuts Nicotine Cravings in Phase 3 Trial | ACHV Stock News - Stock Titan
Brokers Offer Predictions for ACHV Q3 Earnings - Defense World
Tower Research Capital LLC TRC Acquires 4,905 Shares of Achieve Life Sciences, Inc. (NASDAQ:ACHV) - Defense World
What is Zacks Small Cap’s Estimate for ACHV Q2 Earnings? - Defense World
Achieve Life Sciences targets NDA submission for cytisinicline in June 2025 as open label study hits key milestones - MSN
Raymond James Financial Inc. Purchases New Position in Achieve Life Sciences, Inc. (NASDAQ:ACHV) - MarketBeat
Achieve Life Sciences, Inc. (NASDAQ:ACHV) Q1 2025 Earnings Call Transcript - Insider Monkey
ACHV: Kicking Butts to Achieve June NDA Filing - Yahoo Finance
Achieve Life Sciences Inc (ACHV) Q1 2025 Earnings Call Highlights: Strategic Advances Amid ... - Yahoo Finance
Achieve Life Sciences Inc (ACHV) Q1 2025 Earnings Call Highlights: Strategic Advances Amid Financial Challenges - GuruFocus
Earnings call transcript: Achieve Life Sciences Q1 2025 targets nicotine dependence market - Investing.com Nigeria
Earnings call transcript: Achieve Life Sciences Q1 2025 targets nicotine dependence market By Investing.com - Investing.com South Africa
Transcript : Achieve Life Sciences, Inc., Q1 2025 Earnings Call, May 13, 2025 - marketscreener.com
ACHV Prepares for FDA Submission of New Smoking Cessation Drug | - GuruFocus
Achieve Life Sciences Inc Reports Q1 2025 EPS of -$0.37, Aligns with Estimates; Revenue Remains at $0 Million - GuruFocus
ACHIEVE LIFE SCIENCES Earnings Results: $ACHV Reports Quarterly Earnings - Nasdaq
Achieve Life Sciences Reports First Quarter 2025 Financial Resul - GuruFocus
Achieve Life Sciences Reports First Quarter 2025 Financial Results and Highlights Updates in Cytisinicline Program - The Manila Times
Achieve Life Sciences Inc. Q1 Loss Increases In Line With Estimates - Nasdaq
ACHIEVE LIFE SCIENCES, INC. SEC 10-Q Report - TradingView
Achieve Life Sciences, Inc. (NASDAQ:ACHV) Shares Bought by Barclays PLC - Defense World
Raymond James Financial Inc. Takes $554,000 Position in Achieve Life Sciences, Inc. (NASDAQ:ACHV) - Defense World
Wells Fargo & Company MN Boosts Holdings in Achieve Life Sciences, Inc. (NASDAQ:ACHV) - Defense World
Renaissance Technologies LLC Increases Stock Position in Achieve Life Sciences, Inc. (NASDAQ:ACHV) - Defense World
Achieve Life Sciences (ACHV) to Release Quarterly Earnings on Thursday - MarketBeat
Will Cytisinicline Achieve The Long-Awaited Breakthrough In Nicotine Addiction Treatment? - RTTNews
Achieve Life Sciences to Announce First Quarter 2025 Financial R - GuruFocus
Achieve Life Sciences to Announce First Quarter 2025 Financial Results and Host Conference Call and Webcast on May 13, 2025 | ACHV Stock News - GuruFocus
Achieve Life Sciences to Announce First Quarter 2025 Financial Results and Host Conference Call and Webcast on May 13, 2025 - The Manila Times
Achieve Life Sciences to Announce First Quarter 2025 - GlobeNewswire
Achieve Life Sciences to Report Q1 Earnings: Latest Updates on Smoking Cessation Drug Development - Stock Titan
Achieve Life Sciences Inc expected to post a loss of 36 cents a shareEarnings Preview - TradingView
Achieve Life Sciences Inc Azioni (ACHV) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Achieve Life Sciences Inc Azioni (ACHV) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Stewart Richard Alistair | Chieve Executive Officer |
Mar 17 '25 |
Buy |
2.86 |
10,000 |
28,598 |
60,876 |
0.68%
0.50%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):